Moreover, PTEN enzymatic activity is reported to be deficient in CLL (Shehata et al., 2010), suggesting that PTEN post-translational regulation is also altered in hematological cancer. This evidence concerns the gene PTEN and hematopoietic and lymphoid cell neoplasm.